Early Menopause and Diabetes Risk: What the Timing Means

Your periods stopped at forty-one. Or your ovaries came out during a hysterectomy at thirty-nine and the change arrived over a single week rather than over years. Somewhere along the way, someone mentioned that this raises your risk of diabetes — said quickly, with no number attached — and it has been sitting there since.

It is true. It is also smaller, and far more actionable, than it probably sounded. And the most useful thing about knowing your menopause came early has nothing to do with worry: it changes what you are entitled to ask your doctor for.

What counts as early

Two thresholds do most of the work in the research. A last period before 45 is early menopause. Before 40 is premature ovarian insufficiency, or POI — a different category, with its own diagnosis and its own treatment. The 2024 ESHRE and ASRM guideline (opens in a new tab) diagnoses POI on four months or more of disordered cycles together with a single FSH blood level above 25 IU/L. That last detail is new: the older guideline asked for two raised readings, which meant women waited weeks longer for an answer than they now need to.

It is worth knowing where your own date sits, because Pakistani averages run lower than the international ones these thresholds were drawn around. A population-based study of 925 women in Karachi (opens in a new tab) found a mean age at natural menopause of 47.1 years, against the roughly 51 assumed in Western guidance. So a menopause at 46 here is unremarkable and 44 is not far off ordinary — but the thresholds are set by the biology of the years spent without oestrogen, not by local averages, and 44 still counts as early.

The size of the risk, honestly

The largest pooled look at this comes from a meta-analysis of thirteen studies (opens in a new tab) covering 191,762 postmenopausal women, among whom 21,664 had type 2 diabetes. Compared with women whose menopause fell between 45 and 55, the odds of type 2 diabetes were 15% higher with early menopause and 50% higher with POI.

A larger 2023 analysis of twenty cohorts and 921,517 women (opens in a new tab) lands in the same territory and sharpens it. Menopause before 40 carried a 32% higher risk of type 2 diabetes. Menopause at 40 to 45 came out at 11% higher — a figure whose confidence interval crossed one, meaning that for early menopause specifically, the effect is small enough that the evidence cannot yet fully separate it from chance.

You may have seen much bigger numbers. The Rotterdam Study, following 3,639 women, reported risk roughly 3.7 times higher for menopause before 40. Both findings are honest. Rotterdam compared against women whose menopause came after 55 — the most protected group there is — and a single cohort swings wider than pooled evidence does. When you put all the studies together, the realistic picture for POI is something like a third to a half again more risk.

Why timing matters at all

Oestrogen supports the way your body responds to insulin, and it does a good deal else besides. An earlier menopause simply means more years spent without it, and diabetes is one thread in a wider cloth. In that same 2023 analysis, menopause before 40 also carried a 52% higher risk of coronary heart disease and a 27% higher risk of stroke, with cholesterol running higher in both the premature and the early groups.

There is also a possibility worth holding lightly: that early menopause is partly a signal rather than only a cause. In the Rotterdam Study the link to diabetes held up even after accounting for weight, glucose and hormone levels — which is what you would expect if whatever brought menopause forward were also acting on metabolism directly. Either way, the practical response is the same.

In Pakistan, a lot of early menopause arrives by surgery

This is the part most worth passing on to someone else, because unlike the rest of this, it is sometimes preventable.

A study at Dow Medical College in Karachi (opens in a new tab) examined 157 hysterectomies performed on women of reproductive age, average age forty. The ovaries were removed in 68% of them. When pathology examined those ovaries afterwards, 78% turned out to be normal, or to hold nothing more than functional cysts — tissue that had been working fine. The authors' recommendation is plain: ovaries should be conserved when a hysterectomy is being done for bleeding or another uterine cause and there is no radiological or surgical reason to take them.

Removing both ovaries ends oestrogen production the day of the operation, whatever your age. If a hysterectomy is being planned for you or for someone in your family, it is entirely reasonable to ask, before the date is fixed: do my ovaries need to come out, and what is the reason? It is a normal question, and one the surgical literature is asking too.

If you have type 1 diabetes, the arrow may run both ways

There is a long-standing question about whether type 1 diabetes brings menopause forward, and the evidence is genuinely split. The Familial Autoimmune and Diabetes Study (opens in a new tab) compared 143 women with type 1 diabetes against their own non-diabetic sisters and found menopause at 41.6 years versus 49.9 — a gap of about six reproductive years. But the later OVADIA study (opens in a new tab), with 140 women with type 1 diabetes and more than five thousand without, found mean menopause at 49.8 years in both groups and no association at all after adjustment.

The most likely reconciliation is time. The older cohort was diagnosed in the 1950s and 60s, decades before modern glucose management, and OVADIA's authors suggest that better control has spared the small blood vessels the damage that seems to age the ovaries. Which makes the takeaway ordinary rather than alarming: this is one more thing that steady management appears to protect, and if your cycles change in your thirties it is worth raising rather than waiting out.

What early menopause entitles you to ask for

For POI, hormone therapy is not a matter of how much the symptoms bother you. The ESHRE and ASRM guideline recommends it for every woman with POI, continued until the usual age of menopause, as primary prevention — explicitly whether oestrogen deficiency symptoms are present or not. Untreated POI carries reduced life expectancy, largely through cardiovascular disease. This is one of the clearest recommendations in menopause medicine, and one of the least often acted on.

• If your menopause was before 40, ask specifically about hormone therapy as prevention rather than as symptom relief. The two conversations sound different and lead to different places.
• Ask for a lipid profile and a diabetes test at the point of diagnosis — the guideline recommends both, and it is easier to get them done together than to come back for each.
• Between 40 and 45, the case for hormone therapy is a discussion rather than a standing recommendation. Bring your date to it; your doctor may not know it.
• Screen for diabetes on a schedule regardless. The American Diabetes Association's 2026 Standards of Care (opens in a new tab) advise testing every adult by 35 at the latest, repeating at least every three years — which for most women arrives well before menopause does.
• Write the date down somewhere you will find it. Your age at your last period is a piece of medical history you will be asked for repeatedly over the next thirty years, and it gets hazy fast.

Having diabetes does not rule hormone therapy out, and different formulations affect glucose differently — that is a conversation to have with your own history on the table, and there is more on it in our piece on menopause and blood sugar.

Give your doctor something to work with

If your menopause came early, the useful things to have at your next appointment are your date, your recent readings, and any pattern you have noticed since. Logging in Diatic means bringing a record rather than a recollection.

Start logging with Diatic (opens Diatic on Google Play in a new tab)